Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations-Reference-Cited by-同舟云学术

Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations

Published:2006-05-23 Issue:1 Volume:6 Page:
ISSN:1471-2377
Container-title:BMC Neurology
language:en
Short-container-title:BMC Neurol

Author:

Then Bergh Florian,Kümpfel Tania,Schumann Erina,Held Ulrike,Schwan Michaela,Blazevic Mirjana,Wismüller Axel,Holsboer Florian,Yassouridis Alexander,Uhr Manfred,Weber Frank,Daumer Martin,Trenkwalder Claudia,Auer Dorothee P

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),General Medicine

Link

http://link.springer.com/content/pdf/10.1186/1471-2377-6-19.pdf

Reference44 articles.

1. Milligan NM, Newcombe R, Compston DA: A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects. J Neurol Neurosurg Psychiatry. 1987, 50: 511-6.

2. Thompson AJ, Kennard C, Swash M, Summers B, Yuill GM, Shepherd DI, Roche S, Perkin GD, Loizou LA, Ferner R, Hughes RAC, Thompson M, Hand J: Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS. Neurology. 1989, 39: 969-971.

3. Optic Neuritis Study Group: The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial. Neurology. 1997, 49: 1404-1413.

4. Beck RW, Trobe JD, Moke PS, Gal RL, Xing D, Bhatti MT, Brodsky MC, Buckley EG, Chrousos GA, Corbett J, Eggenberger E, Goodwin JA, Katz B, Kaufman DI, Keltner JL, Kupersmith MJ, Miller NR, Nazarian S, Orengo-Nania S, Savino PJ, Shults WT, Smith CH, Wall M: High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol. 2003, 121: 944-949. 10.1001/archopht.121.7.944.

5. Kaufman DI, Trobe JD, Eggenberger ER, Whitaker JN: Practice parameter: The role of corticosteroids in the management of acute monosymptomatic optic neuritis: Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000, 54: 2039-2044.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medication and bone health in multiple sclerosis: A systematic review and meta-analysis;Journal of Managed Care & Specialty Pharmacy;2023-12

2. Repurposing Domperidone in Secondary Progressive Multiple Sclerosis;Neurology;2021-03-23

3. Corneal Graft Rejection after Yellow Fever Vaccine: A Case Report;Ocular Immunology and Inflammation;2021-01-28

4. Comparing Plasma Exchange to Escalated Methyl Prednisolone in Refractory Multiple Sclerosis Relapses;Journal of Clinical Medicine;2019-12-22

5. An asymptomatic new lesion on MRI is a relapse and should be treated accordingly – Yes;Multiple Sclerosis Journal;2019-11-01